Correlation between magnetic resonance imaging findings and lesion development in chronic, active multiple sclerosis

Annals of Neurology

Volumn 34, Issue 5, 1993, Pages 661-669

  Katz, David ^a,b   Taubenberger, Jeffery K ^b   Cannella, Barbara ^c   McFarlin, Dale E ^a   Raine, Cedric S ^c   McFarland, Henry F ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b National Institutes   (United States)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GADOLINIUM PENTETATE;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; CONTRAST ENHANCEMENT; FEMALE; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MULTIPLE SCLEROSIS; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

ADULT; BRAIN; CASE REPORT; CEREBRAL CORTEX; CHRONIC DISEASE; CONTRAST MEDIA; FEMALE; GADOLINIUM DTPA; HLA ANTIGENS; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; ORGANOMETALLIC COMPOUNDS; PENTETIC ACID; PONS; SPINAL CORD; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0027503708     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.410340507     Document Type: Article

References (29)

1. Nuclear magnetic resonance imaging of the brain in multiple sclerosis
2. Nuclear magnetic resonance imaging in multiple sclerosis
3. The role of NMR imaging in the assessment of multiple sclerosis and isolated neurological lesions: a quantitative study
4. MRI in the diagnosis of MS: a prospective study and comparison of clinical evaluation, evoked potentials, oligoclonal banding and CT
5. Multiple sclerosis: gadolinium enhancement in MR imaging
6. Serial study of gadolinium‐DTPA MRI enhancement in multiple sclerosis
7. Breakdown of the blood‐brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis
8. Duration and selectivity of blood‐brain barrier breakdown in chronic relapsing experimental allergic encephalomyelitis studied by gadolinium‐DTPA and protein markers
9. On the immunopathology of plaque development and repair in MS
10. The Multiple Sclerosis Study Group. Efficacy and toxicology of cyclosporine in chronic progressive multiple sclerosis: a randomized, double blinded, placebo‐controlled clinical trial
11. Remyelination in the human central nervous system
12. Interaction of astrocytes and newly formed oligodendrocytes in resolving multiple sclerosis lesions
13. Multiple sclerosis: interactions between oligodendrocytes and hypertrophic astrocytes and their occurrence in other, non‐demyelinating conditions
14. Multiple sclerosis: remyelination in acute lesions
15. Multiple sclerosis: serial study of gadolinium‐enhanced MR imaging
16. Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis
17. Serial gadolinium‐enhanced magnetic resonance imaging scans in patients with early, relapsing multiple sclerosis: implication for clinical trials and natural history
18. The morbid anatomy of the demyelinating diseases
19. Histopathology of multiple sclerosis lesions detected by magnetic resonance imaging in unfixed postmortem central nervous system tissue
20. Stereotactic biopsy of an active multiple sclerosis lesion
21. Multiple sclerosis: histopathology and MR and/or CT correlation in 37 cases at biopsy and three cases autopsy
22. The effect of high‐dose steroids on MRI gadolinium enhancement in acute demyelinating lesions
23. A correlation triad of gadolinium‐DTPA MRI, EDSS, and CSF‐MBP in relapsing multiple sclerosis patients treated with high dosage intravenous methylprednisolone
24. Quantitative MRI changes in gadolinium‐DTPA enhancement after high‐dose intravenous methylprednisolone in multiple sclerosis
25. High‐dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect
26. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions
27. Demyelinating diseases
28. Multiple sclerosis: a pivotal role for the T cell in lesion development
29. Low dose cyclosporine induces relapsing experimental allergic encephalomyelitis in the Lewis rat